Embecta Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
Analysts Offer Insights on Healthcare Companies: McKesson (MCK), Embecta Corporation (EMBC) and Abbott Labs (ABT)
Analysts Offer Insights on Healthcare Companies: Embecta Corporation (EMBC), Mettler-Toledo (MTD) and Humacyte (HUMA)
Morgan Stanley Adjusts Price Target on to $16 From $15, Maintains Underweight Rating
Embecta Analyst Ratings
Embecta Corporation (EMBC) Receives a Hold From BTIG
Analysts Offer Insights on Technology Companies: Cognizant (CTSH), Embecta Corporation (EMBC) and SolarEdge Technologies (SEDG)
Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $15
Embecta Analyst Ratings
BofA Trims Price Target on Embecta to $17 From $25, Keeps Underperform Rating
Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $16
Embecta Analyst Ratings
Embecta Corporation (EMBC) Gets a Sell From Bank of America Securities
Morgan Stanley Adjusts Price Target on Embecta to $19 From $29, Maintains Underweight Rating
Morgan Stanley Maintains Underweight on Embecta, Lowers Price Target to $19
Embecta Analyst Ratings
Analysts Offer Insights on Technology Companies: Embecta Corporation (EMBC), Fastly (FSLY) and Gitlab (GTLB)
BTIG Sticks to Its Hold Rating for Embecta Corporation (EMBC)
Embecta Analyst Ratings